Articles by Larissa Ku
CDH, Huaxing lead $120m Series B for China's InnoRNA
CDH Investments and Huaxing Healthcare Fund have led a USD 120m Series B for InnoRNA, a China-based mRNA drug developer. Existing investors CPE and Fangyuan Capital re-upped.
China EV maker Eezi raises $78m
Shenzhen-based electronic vehicle (EV) manufacturer Eezi has raised a CNY 500m (USD 78m) pre-A round led by China Merchants Venture.
GP profile: DCM
Investing in China, Japan, and the US out of a single global fund, DCM sticks to a formula of small funds, concentrated portfolios, early-stage deals, and collaborative cross-border teams
Investment becomes Tencent's main profit driver in 2021
Investment accounted for the bulk of Tencent Holdings' annual profit for the first time in 2021 as the Chinese technology giant saw earnings from its core business contract in the second half of the year.
CBC strikes China's first royalty-based biomedicine deal
R-Bridge Fund, a credit vehicle established by healthcare-focused private equity firm CBC Group, has completed what it claims is the first royalty-backed investment in China’s biomedicine space.
China enterprise AR specialist Rokid raises $160m
Rokid, a China-based company specialising in augmented reality (AR) technology applications, has raised USD 160m in Series C funding across two tranches.
China AI start-up Aibee joins unicorn club
China-based artificial intelligence start-up Aibee has achieved a valuation of more than USD 1bn on closing a new funding round led by smartphone brand Xiaomi and featuring China Merchants Capital.
Eight Roads launches $350m China tech fund
Eight Roads Ventures has raised a China fund with a corpus of USD 350m which will make venture and early growth investments across enterprise, financial, and consumer technologies
Deal focus: Medilink chases global ADC opportunity
The Medilink Therapeutics team spun out from Kelun-Biotech to develop antibody drug conjugates capable of competing with the world’s best. Its USD 70m Series B will support the pursuit of this goal
China's Nio Capital closes Fund II on $400m
Nio Capital, a China-based investment firm established by the founder of domestic electric vehicle (EV) manufacturer Nio, has raised USD 400m for its second US-dollar denominated fund.
Hong Kong digital asset custodian Hex Trust raises $88m
Hong Kong-based digital asset custodian Hex Trust has raised a USD 88m Series B round co-led by local counterpart Animoca Brands and US crypto specialist Liberty City Ventures.
China smart projector brand JMGO raises $158m
IDG Capital and Chinese smartphone brand Oppo have invested CNY 1bn (USD 158m) in JMGO, a local manufacturer of smart projection equipment developer JMGO that also goes by the name Holatek.
Genesis leads Series A extension for China's Nutshell Therapeutics
Nutshell Therapeutics, a China-based specialist in protein-focused drugs, has raised USD 40m in an extended Series A led by Genesis Capital.
Lyfe, Qiming lead Series B for China ADC player Medilink
Suzhou Medilink Therapeutics, a Chinese biotech company specializing in antibody-drug conjugates (ADCs) commonly used as targeted therapies for treating cancer, has raised a USD 70m Series B led by Lyfe Capital and Qiming Venture Partners.
Deal focus: Mighty Jaxx revels in 'phygital' bridge role
In collectables maker Mighty Jaxx, East Ventures saw not only an effective traditional retail brand, but a company capable of elevating the user experience by straddling the digital and physical worlds
China 3D content platform Xverse raises $120m
Xverse, a Shenzhen-based 3D user-generated content platform has raised USD 120m across a Series A and a Series A extension, led by GL Ventures and Sequoia Capital China, respectively.
Source Code leads Series B for China's Fair Robotics
Fair Robotics, a China-based collaborative robot developer, has raised a USD 50m Series B round led by Source Code Capital.
China's Cloudview reaches $316m first close on renminbi fund
Cloudview Capital, a Chinese GP that previously operated as a joint venture with ICBC International, has completed a first close on its second renminbi-denominated Fund with CNY 2bn (USD 316m) in commitments.
China smart text processing start-up raises $92m
Data Grand, a China-based specialist in text recognition and processing robotics, has raised CNY 580m （USD 92m）in Series C round featuring China Merchants Securities, CITIC Securities, GF Securities, and China Securities.
East leads $20m round for Singapore's Mighty Jaxx
Singapore-based toy figurine manufacturer Mighty Jaxx has raised USD 20m in an extended Series A led by East Ventures. Crypto specialist Mirana Ventures also participated.
China's Pony.ai hits $8.5b valuation with Series D
Chinese autonomous driving technology supplier Pony.ai has closed the first tranche of a Series D round at a valuation of USD 8.5bn. This represents a 65% increase from the Series C.
Deal focus: Inspiration snares rare China mid-cap tech buyout
Antute, a third-party IT maintenance provider, became an orphan asset following a larger M&A deal. Inspiration Capital Partners sees it as an attractive play on China’s digitalisation drive
Deal focus: Freemium works for Dianxiaomi
China cross-border e-commerce services platform Dianxiaomi has achieved traction, and profitability, by only charging for value-added services. Its Series C will fuel global expansion
China cancer drug developer InxMed raises $50m
InxMed, a China-based biotech company focused on oncology treatments, has raised a USD 50m Series B round led by SDIC China Merchants Investment.